In these patients already treated or undergoing treatment for chronic viral hepatitis, from a carcinogenic point of view, although ALT elevation due to viral infection is controlled, attention should also be paid to ALT elevation due to other factors, such as metabolic dysfunction-associated fatty liver disease and alcoholic liver disease. This evidence concerns the gene GPT and viral infectious disease.